NCT05119777View on ClinicalTrials.gov

HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2023

Conditions

Soft Tissue Augmentation

Interventions

DEVICE

HArmonyCa Injectable Gel

Subdermal or deep dermal injection

Trial Locations (2)

13594

Eurofins Dermscan Pharmascan /ID# 240921, Aix-en-Provence

69100

Eurofins Pharmascan /ID# 240920, Lyon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY